Working as Market Access Director at Boehringer Ingelheim Turkey, Begüm Minisker was appointed as Pricing and Market Access Manager to Boehringer Ingelheim Germany Corporate Inflammation team.
Operating in three business areas: human health, animal health and biopharmaceuticals, Boehringer Ingelheim Turkey continues to make global appointments. The company announced that Begüm Minisker, who serves as Market Access Director, has been appointed as Pricing and Market Access Manager to Boehringer Ingelheim Germany Corporate Inflammation team.
Begüm Minisker, who has achieved success in different positions within Boehringer Ingelheim Turkey for many years, will develop strategies in the field of market/patient access together with the global project team in her new position. Minisker will also be responsible for developing and implementing the main projects for optimal patient access with the Marketing and Medical teams within the long-term global strategic plan.
